Technological offer

Penicillium strain that produces a highly active antifungal protein (AFP), namely PeAfpA, which is effective against pathogenic and food spoilage fungi. The strain has also been modified to eliminate its antibiotic resistance genes, ensuring its safe use in agriculture, food, and biomedical applications.

A robotic system equipped with a gripper designed to assist medical professionals—such as nurses, surgeons, and doctors—in sterile environments. The gripper can retrieve medical pouches from a table, grasp each individual flap, and open the pouch seal to offer its contents while maintaining aseptic conditions.

A protein domain has been identified with the ability to direct membrane proteins and polypeptides of interest to the zymogen granules of pancreatic cells.

New compounds to treat parasitic diseases such as Chagas disease, leishmaniasis and trypanosomiasias. These derivatives act on a new target: G-cuadruplex DNA

Compounds useful as reversible visible-light-regulated antagonists for the localized and temporally restricted activation of beta-adrenoceptors, with application for the treatment of ocular diseases such as glaucoma.

Technology based on a novel fungal enzymatic activity expressed in a tunable system, designed for the controlled production of hyaluronic acid oligosaccharides with defined structures and bioactive functionality.

Method that enables the rapid and homogeneous formation of three-dimensional cell spheroids, facilitating their production through automated systems for biomedical research and pharmaceutical development.

New antiviral compound against HSV-1 and HSV-2 that can be used in combination with other drugs or to treat resistant strains to conventional antivirals.

Selective SGK1 kinase inhibitors, blood-brain barrier-permeable, as drug candidates for the treatment of neurodegenerative diseases (such as Parkinson’s or Alzheimer’s disease) or cardiovascular diseases (such as hypertension).

New family of compounds with demonstrated in vitro efficacy against intracellular parasites responsible for leishmaniasis and American trypanosomiasis or Chagas disease. Pharmacokinetic and toxicity studies have been conducted in rats, as well as preliminary efficacy studies in a murine model.